Dr. Émilie Renaud

Dr. Émilie Renaud is a clinical pharmacologist with over 15 years of experience in the development and evaluation of therapeutic peptides.

Her career spans academic research at Imperial College London and Institut Pasteur, to the pharmaceutical industry at Ipsen Pharma, where she contributed to the clinical development of several peptide molecules, including Somatuline® and Decapeptyl®.

Now an independent consultant, Dr. Renaud advises biotech companies on clinical development strategies and health publishers on scientific content validation.

• Peptide pharmacokinetics: absorption, distribution, metabolism, elimination
• Safety profiles: drug interactions, adverse effects
• Regulatory affairs: EMA and FDA procedures
• Medical review: scientific fact-checking, content validation
• Therapeutic peptides: somatostatin analogs, GnRH, GLP-1

Certifications:

• Board Certified Clinical Pharmacologist — European Board of Clinical Pharmacology
• Registered Pharmacist — French National Order of Pharmacists, Section B
• Good Clinical Practice (GCP) — TransCelerate BioPharma
• Medical Writing Certification — AMWA

1. Renaud E, et al. "Stability and bioavailability of synthetic pentadecapeptides: a systematic review." European Journal of Pharmaceutical Sciences. 2019;138:105024.
2. Renaud E, et al. "Pharmacokinetic considerations in peptide-based regenerative medicine." Clinical Pharmacology & Therapeutics. 2021;109(3):612-624.
3. Renaud E, Owen D. "Peptide receptor internalization: implications for drug design." British Journal of Pharmacology. 2011;164(4):1052-1067.

Dr. Renaud serves as Lead Medical Reviewer for Klow Peptide, overseeing the scientific validation of content related to peptide pharmacology and safety.

Her role includes:

• Scientific review of general peptide guides
• Verification of pharmacokinetic profiles and safety data
• Validation of drug interaction information
• Oversight of YMYL compliance standards

Articles reviewed by Dr. Renaud are marked with her credentials to indicate expert medical oversight.

Connect: LinkedIn Profile